Showing results (171-180 of 529) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|May 26, 2021
Medical treatment of heart failure with reduced ejection fraction: the dawn of a new era of personalized treatment?Pietro Ameri, Edoardo Bertero, Christoph Maack, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 12, 2023
Cardiovascular outcomes in hepatitis C virus infected patients treated with direct acting antiviral therapy: a retrospective multi-institutional studyVictor Chien-Chia Wu, Chien-Hao Huang, Chun-Li Wang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 15, 2020
Prediction of the early response to spironolactone in resistant hypertension by the combination of matrix metalloproteinase-9 activity and arterial stiffness parametersElena Rodríguez-Sánchez, José Alberto Navarro-García, Jennifer Aceves-Ripoll, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 10, 2020
Cost-utility of ticagrelor plus aspirin in diabetic patients with stable coronary artery diseaseBin Wu, Lizheng Shi
European Heart Journal. Cardiovascular Pharmacotherapy|August 14, 2020
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe studyJoris R de Groot, Thomas W Weiss, Peter Kelly, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 31, 2020
The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarctionDaniel A Jones, Paul Wright, Momin A Alizadeh, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 4, 2023
Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes-a substudy of the TROPICAL-ACS trialAndrás Komócsi, Béla Merkely, Martin Hadamitzky, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 5, 2023
Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapyRobert A Sykes, Karla B Neves, Rhéure Alves-Lopes, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 1, 2022
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR RegistryMaría A Esteve-Pastor, José M Rivera-Caravaca, Vanessa Roldán, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 1, 2022
Immunomodulatory effect of different statin regimens on regulatory T-cells in patients with acute coronary syndrome: a systematic review and network meta-analysis of randomized clinical trialsElona Greca, Ous Kacimi, Sujan Poudel, et al.
Pageof 53